Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.34 |
| ▸ | BRD1 | O95696 | 1/20 | 0.34 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1160297 | 1.00 | MEN1 (0.34) | MEN1KMT2ATRIM24BRD1BRPF1 | |
| SCHEMBL29367415 | 0.88 | ALDH1A1 (0.39) | MEN1KMT2ATP53MAPTMRGPRX4 | |
| SCHEMBL132991 | 0.88 | ALDH1A1 (0.39) | MEN1KMT2ATP53MAPTMRGPRX4 | |
| SCHEMBL29085688 | 0.88 | MRGPRX4 (0.41) | TP53MRGPRX4TDP1CYP2A6SMN1; SMN2 | |
| SCHEMBL11268124 | 0.86 | ACHE (0.46) | MEN1KMT2ATRIM24BRPF1TP53 | |
| SCHEMBL6165769 | 0.84 | APEX1 (0.38) | MEN1KMT2AMAPTMRGPRX4TDP1 | |
| SCHEMBL9240542 | 0.84 | APEX1 (0.38) | MEN1KMT2AMAPTMRGPRX4TDP1 | |
| SCHEMBL30491175 | 0.84 | APEX1 (0.38) | MEN1KMT2AMAPTMRGPRX4TDP1 | |
| SCHEMBL2570822 | 0.82 | TDP1 (0.41) | TP53MAPTTDP1HTTALDH1A1 | |
| SCHEMBL381269 | 0.82 | TDP1 (0.41) | TP53MAPTTDP1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1312598-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2005-02-16 | — | — | EP | disclosed |
| EP-1008581-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2004-04-21 | — | — | EP | disclosed |
| US-6610891-B1 | Reduces degradation or decomposition of catalyst | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-08-26 | — | — | US | disclosed |
| US-6583324-B2 | By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-24 | — | — | US | disclosed |
| EP-1312598-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-20020049355-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-04-25 | — | — | US | disclosed |
| US-6291717-B1 | REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST COMPRISING RHODIUM AND ORGANIC PHOSPHITE IN REACTION ZONE; SEPARATING CATALYST AND ALDEHYDE; RECYCLING CATALYST SOLUTION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-1008581-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-06-14 | — | — | EP | disclosed |
| US-5672766-A | REACTING OLEFIN WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049355-A1 | Process for producing aldehyde | ALDH2, OGDH, HAO2 | MEN1 3237/4885KMT2A 2019/4885TRIM24 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.